- Home
- PHAR vs GHY Comparison
PHAR vs GHY Comparison
Compare PHAR & GHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- GHY
- Stock Information
- Founded
- PHAR 1988
- GHY 2012
- Country
- PHAR Netherlands
- GHY United States
- Employees
- PHAR N/A
- GHY N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- GHY Trusts Except Educational Religious and Charitable
- Sector
- PHAR Health Care
- GHY Finance
- Exchange
- PHAR Nasdaq
- GHY Nasdaq
- Market Cap
- PHAR 624.1M
- GHY 528.3M
- IPO Year
- PHAR N/A
- GHY N/A
- Fundamental
- Price
- PHAR $8.86
- GHY $13.25
- Analyst Decision
- PHAR Strong Buy
- GHY
- Analyst Count
- PHAR 3
- GHY 0
- Target Price
- PHAR $27.00
- GHY N/A
- AVG Volume (30 Days)
- PHAR 5.9K
- GHY 184.8K
- Earning Date
- PHAR 03-13-2025
- GHY 01-01-0001
- Dividend Yield
- PHAR N/A
- GHY 10.58%
- EPS Growth
- PHAR N/A
- GHY N/A
- EPS
- PHAR N/A
- GHY N/A
- Revenue
- PHAR $285,745,000.00
- GHY N/A
- Revenue This Year
- PHAR $20.08
- GHY N/A
- Revenue Next Year
- PHAR $9.22
- GHY N/A
- P/E Ratio
- PHAR N/A
- GHY N/A
- Revenue Growth
- PHAR 30.64
- GHY N/A
- 52 Week Low
- PHAR $6.65
- GHY $10.24
- 52 Week High
- PHAR $12.20
- GHY $11.92
- Technical
- Relative Strength Index (RSI)
- PHAR 48.50
- GHY 54.89
- Support Level
- PHAR $8.50
- GHY $13.06
- Resistance Level
- PHAR $9.50
- GHY $13.54
- Average True Range (ATR)
- PHAR 0.56
- GHY 0.17
- MACD
- PHAR 0.03
- GHY -0.02
- Stochastic Oscillator
- PHAR 58.71
- GHY 53.23
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.